COPD and Asthma Devices Market by Product Type, Distribution Channel, End User 2024-2032

1
Global COPD and Asthma Devices Market Research
and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "COPD and Asthma Devices Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global COPD and
  asthma devices market size reached US 45.7
  Billion in 2023.
• COPD and asthma devices are medical equipment
  designed to help patients manage their symptoms
  of chronic obstructive pulmonary disease (COPD)
  and asthma. They provide the user with data on
  respiratory functions, along with therapy to aid
  in controlling their symptoms. COPD devices help
  in monitoring lung function, tracking
  medications, detecting early signs of
  exacerbations, and providing reminders for
  treatments.
• On the other hand, asthma devices provide data on
  air quality levels and monitor peak flow
  measurements and other asthma triggers. The
  demand for COPD and asthma devices is continually
  increasing as they improve the quality of life of
  the patients by providing the user with the tools
  they need to manage their condition better.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/copd-asthma-devices-mar
  ket/requestsample

4
Report Description

• Global COPD and Asthma Devices Market Trends
• The rising prevalence of chronic diseases among
  the masses majorly drives the global market. This
  can be supported by the growing pollution levels
  and the escalating number of cigarette smokers
  across the globe. Coupled with this, the
  increasing incidences of chronic respiratory
  diseases (CRDs), including chronic obstructive
  pulmonary disease (COPD), lung disorders,
  pulmonary hypertension (PH), bronchial asthma,
  and cystic fibrosis among individuals, are
  catalyzing the demand for COPD and asthma
  devices. Apart from this, the occupational
  exposure to dust in forestry, mining, and
  agricultural sectors is also accelerating the
  demand for effective airway management devices,
  thereby propelling the market.
• In addition, the augmenting adoption of connected
  medical devices among healthcare professionals to
  ensure that patients receive the best care and
  consultation possible, regardless of the
  circumstance, is acting as a growth-inducing
  factor. Moreover, various leading manufacturers
  are developing more effective and efficient COPD
  and asthma devices to improve the efficiency of
  medication management, along with continuous
  developments in home-based COPD and asthma
  treatments, thus creating a positive market
  outlook. Some of the other factors driving the
  market include the rising healthcare expenditure
  and growing reimbursement schemes offered by
  health insurance companies.
• Looking forward, the market is anticipated to
  reach a value of US 69.5 Billion by 2032,
  exhibiting a CAGR of 4.6 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/copd-asthma-devices-mar
  ket

5
Report Segmentation

• Breakup by Product
• Inhalers
• Drug Powdered Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• Soft Mist Inhalers
• Nebulizers
• Compressor Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers
•  Breakup by Indication
• Asthma
• COPD
• Breakup by Distribution Channel
• Retail Pharmacies

6
Report Segmentation

• Hospitals
• Online Pharmacies
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Adherium Limited
• Aristopharma Ltd.
• AstraZeneca PLC
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cohero Health Inc.
• Koninklijke Philips N.V.
• Omron Corporation
• Pari Respiratory Equipment Inc.
• Recipharm AB
• Verona Pharma plc.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global COPD and Asthma
  Devices Market    5.1    Market Overview    5.2
     Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product    6.1  
   Inhalers        6.1.1 Market Trends       
  6.1.2 Key Segments           6.1.2.1 Drug
  Powdered Inhalers (DPIs)           6.1.2.2
  Metered Dose Inhalers (MDIs)           6.1.2.3
  Soft Mist Inhalers        6.1.3 Market
  Forecast    6.2    Nebulizers        6.2.1
  Market Trends        6.2.2 Key Segments       

10
Table of Contents

•            6.2.2.1 Compressor Nebulizers       
     6.2.2.2 Ultrasonic Nebulizers         
   6.2.2.3 Mesh Nebulizers        6.2.3 Market
  Forecast7   Market Breakup by Indication    7.1
     Asthma        7.1.1 Market Trends       
  7.1.2 Market Forecast    7.2    COPD       
  7.2.1 Market Trends        7.2.2 Market
  Forecast8   Market Breakup by Distribution
  Channel    8.1    Retail Pharmacies       
  8.1.1 Market Trends        8.1.2 Market
  Forecast    8.2    Hospitals        8.2.1
  Market Trends        8.2.2 Market Forecast   
  8.3    Online Pharmacies        8.3.1 Market
  Trends        8.3.2 Market Forecast9   Market
  Breakup by Region    9.1    North America     
    9.1.1 United States           9.1.1.1 Market
  Trends           9.1.1.2 Market Forecast       
  9.1.2 Canada           9.1.2.1 Market Trends   
         9.1.2.2 Market Forecast    9.2  
   Asia-Pacific
• For more information, visit https//www.imarcgrou
  p.com/copd-asthma-devices-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com